Skip to content
← Clinical Cases

Transplant — clinical cases

29 questions

Sample cases

  1. Case 1

    A 45-year-old man receives a deceased-donor kidney transplant. He is at low immunologic risk (first transplant, no donor-specific antibodies) and receives basiliximab induction. According to KDIGO, which maintenance regimen is preferred?

    • A.Tacrolimus plus mycophenolate, with or without prednisone
    • B.Cyclosporine plus azathioprine, with or without prednisone
    • C.Sirolimus plus mycophenolate started on the day of surgery
    • D.Mycophenolate plus prednisone without a calcineurin inhibitor
  2. Case 2

    A 38-year-old woman with three previous pregnancies and a failed first kidney graft is receiving a second kidney transplant. Her calculated panel-reactive antibody is 92%. Which induction approach do KDIGO guidelines suggest for her?

    • A.An interleukin-2 receptor antagonist such as basiliximab
    • B.No biologic induction, with high-dose tacrolimus from day 1
    • C.A lymphocyte-depleting antibody such as rabbit anti-thymocyte globulin
    • D.Intravenous immunoglobulin alone in place of antibody induction
  3. Case 3

    A 52-year-old man is on day 3 of rabbit anti-thymocyte globulin induction after kidney transplantation. Today's labs: WBC 2.6 ×109/L (2,600/mm3), platelets 140 ×109/L (140,000/mm3). According to the US prescribing information, what should be done with today's dose?

    • A.Give the full planned dose with closer monitoring
    • B.Stop anti-thymocyte globulin for the rest of the course
    • C.Give one-quarter of the planned dose
    • D.Give one-half of the planned dose